Results 81 to 90 of about 7,304,609 (309)

A Writer Speaks: An Interview with Lorenz Bell Graham [PDF]

open access: yes, 1983
Missionary, teacher, professor, strikebreaker, cook, waiter, and author are embodied in the national treasure interviewed here. Lorenz Graham received an honorary Doctorate of Letters from his alma mater forty-seven years after receiving the B.A. degree.
Irby, Charles C.
core   +1 more source

Sex Representation in US Stroke Clinical Trials: A Decade of Trends and Challenges

open access: yesAnnals of Clinical and Translational Neurology, EarlyView.
ABSTRACT Objective Stroke remains a major cause of disability and mortality in the US, with significant sex‐based disparities, and females remain underrepresented in stroke clinical trials. We aimed to examine sex representation in US‐based stroke clinical trials, identify trial characteristics associated with higher female enrollment (≥ 50%), and ...
Chaitali Dagli   +5 more
wiley   +1 more source

Historia, memoria y desecho en lugares del Nacionalsocialismo

open access: yesRevista de Arqueologia, 2016
Las preguntas que conducen este trabajo se relacionan, por un lado, con los lugares de memoria; y por el otro, con cómo un lugar de la historia se convierte en lugar del recuerdo, y sus implicancias, desde una perspectiva arqueológica.
Gonzalo Compañy
doaj   +1 more source

Work design improvement at Miroad Rubber Industries Sdn. Bhd. [PDF]

open access: yes, 2020
Erul Food Industries known as Salaiport Industry is a family-owned company and was established on July 2017. Salaiport Industry apparently moved to a new place at Pedas, Negeri Sembilan.
Chen, Xue Chee   +7 more
core  

The European Model Company Law Act project [PDF]

open access: yes, 2008
On 27 and 28 September 2007, a commission formed on the initiative of the authors held its first meeting in Aarhus, Denmark to deliberate on its goal of drafting a "European Model Company Law Act" (EMCLA).
Baums, Theodor, Krüger Andersen, Paul
core   +1 more source

Multiple Sclerosis Relapse Activity After Ozanimod Discontinuation in DAYBREAK Trial Participants

open access: yesAnnals of Clinical and Translational Neurology, EarlyView.
Multiple Sclerosis Relapse Activity After Ozanimod Discontinuation in DAYBREAK Trial Participants. ABSTRACT Objective Return of disease activity is expected when patients discontinue disease‐modifying therapy (DMT) for multiple sclerosis (MS). Some MS DMTs are associated with higher‐than‐expected disease activity (rebound) after discontinuation.
Ralf Gold   +12 more
wiley   +1 more source

A Public Law Approach to Internet Standard Setting

open access: yesGöttingen Journal of International Law, 2016
This article lays the foundations of a comprehensive analysis of the legitimacy of global Internet governance institutions from the perspective of public law.
Biel Company
doaj   +1 more source

Work Organisation and Innovation - Case Study: Company X, Slovenia [PDF]

open access: yes, 2013
[Excerpt] Company X is one of the largest and most successful commercial grocery retailing chains in south-eastern Europe (Euromonitor, 2011). It was established over 60 years ago in Ljubljana, Slovenia.
Darija, Aleksić   +2 more
core   +1 more source

CSF Monoamine Metabolites and Cognitive Trajectory in Early Parkinson's Disease

open access: yesAnnals of Clinical and Translational Neurology, EarlyView.
ABSTRACT Background Imaging and postmortem studies indicate that abnormalities in monoaminergic neurotransmission contribute to cognitive impairment in Parkinson's disease (PD). However, it remains uncertain if cerebrospinal fluid (CSF) monoamine metabolites can serve as biomarkers of cognitive decline in early PD.
Jing‐Yu Shao   +7 more
wiley   +1 more source

The Bellona Company\u27s Case [PDF]

open access: yes, 2016
The Bellona Gunpowder Company of Maryland was one of Maryland’s most prominent gunpowder manufactories during the early nineteenth century. Founded in 1801, the gunpowder company become the second leading gunpowder producer for the American government ...
Conrad, Casey
core   +1 more source

Home - About - Disclaimer - Privacy